title: Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of rats.
authors.affiliation: Department of Neurosymptomatic Disorders, Merck Research Laboratories, West Point, PA 19486, USA. celina_zerbinatti@merck.com.
authors.forename: Sokreine
authors.initials: S
authors.lastname: Suon
authors.forename: Jie
authors.initials: J
authors.lastname: Zhao
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Villarreal
authors.forename: Nikesh
authors.initials: N
authors.lastname: Anumula
authors.forename: Mali
authors.initials: M
authors.lastname: Liu
authors.forename: Linda M
authors.initials: LM
authors.lastname: Carangia
authors.forename: John J
authors.initials: JJ
authors.lastname: Renger
authors.forename: Celina V
authors.initials: CV
authors.lastname: Zerbinatti